Health
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages – News-Medical.Net
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses…
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The researchers from CureVac AG in Tübingen and the Friedrich-Loeffler-Institute in Greifswald-Insel Riems say that compared with their previous vaccine candidate – CvnCoV – the second-generation CV2CoV vaccine accelerated induction of neutralizing antibody titers…
Continue Reading
